Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review

Background Although up to one in five cases of hepatocellular carcinoma (HCC) occurs in patients without cirrhosis, there is scarce literature characterizing non-cirrhotic HCC (NCHCC). Existing NCHCC research is primarily limited to surgical case series and there is a lack of data on unresectable NCHCC. Aim The purpose of this retrospective review was to compare the characteristics of unresectable NCHCC and cirrhotic hepatocellular carcinoma (CHCC). Methods A retrospective chart review of adult patients with unresectable HCC treated from 2007 to 2017 was performed at the University of Florida Shands Hospital. The data set was stratified into two cohorts: NCHCC and CHCC. Continuous variables were compared using Wilcoxon-Mann–Whitney tests and Kruskal–Wallis rank-sum tests. Categorical variables were compared using Pearson’s Chi-squared tests and Fisher’s exact tests. Overall survival was explored utilizing the Kaplan-Meier and log-rank method. Results There were 1494 adult patients included in the final analysis, including 264 patients (17.7%) with NCHCC and 1230 patients (82.3%) with CHCC. Median age was 61.0 years old and median follow-up time was 30.2 months. NCHCC patients were older than CHCC patients (66.3 years vs 61.9 years; p < 0.0001). NHCC tumors were larger than CHCC tumors (7.92 ± 4.85 vs 4.38 ± 3.12 cm; p < 0.0001) and more likely to be associated with distant metastases (23.35% vs 15.91%; p = 0.0055). There was no difference in overall survival, with a median of 23.5 months in NCHCC and 22.4 months in CHCC (p = 0.9196). Conclusion Our findings suggest that unresectable NCHCC and CHCC have unique characteristics but similar overall survival. To the best of our knowledge, this is the largest comparison of CHCC and NCHCC.

[1]  Hongyang Wang,et al.  The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma , 2021, Cancer biology & medicine.

[2]  H. Goyal,et al.  Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements , 2021, World journal of gastroenterology.

[3]  E. Vibert,et al.  Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor , 2021, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  D. Sandhu,et al.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review , 2019, World journal of hepatology.

[5]  J. Lee,et al.  Primary malignant tumours in the non-cirrhotic liver. , 2017, European journal of radiology.

[6]  P. Siersema,et al.  Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands , 2016, European journal of gastroenterology & hepatology.

[7]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[8]  P. Malfertheiner,et al.  Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver , 2014, BMC Gastroenterology.

[9]  Michael F. McNeeley,et al.  Hepatocellular carcinoma in the noncirrhotic liver. , 2014, AJR. American journal of roentgenology.

[10]  Marcus Schuchmann,et al.  Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009: An Analysis of 1066 Cases of a German HCC Registry , 2014, Journal of clinical gastroenterology.

[11]  M. Zoli,et al.  Hepatocellular carcinoma in patients without cirrhosis in Italy. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  W. Hop,et al.  Liver transplantation for unresectable hepatocellular carcinoma in normal livers. , 2012, Journal of hepatology.

[13]  P. Galle,et al.  Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver , 2012, Scandinavian journal of gastroenterology.

[14]  G. Launoy,et al.  Treatment and prognosis of hepatocellular carcinoma: A population based study in France , 2008, Journal of surgical oncology.

[15]  B. Meunier,et al.  Transplantation hépatique pour carcinome hépatocellulaire , 2005 .

[16]  A. Gardini,et al.  Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long‐term survival and tumour recurrence in a single centre , 2003, Alimentary pharmacology & therapeutics.

[17]  J. Zucman‐Rossi,et al.  Hepatocellular carcinoma , 1998, Nature Reviews Disease Primers.

[18]  L. Melton,et al.  Hepatoma in the noncirrhotic liver , 1988, Cancer.

[19]  Y. Hoshida,et al.  Hepatocellular Carcinoma: Translational Precision Medicine Approaches , 2019, Molecular and Translational Medicine.

[20]  K. Ishak,et al.  Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. , 1996, American journal of clinical pathology.

[21]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.